Prestige Consumer Healthcare (PBH) Capital Expenditures (QoQ) (2010 - 2025)
Prestige Consumer Healthcare (PBH) Capital Expenditures (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 44.05% |
| Sep 30, 2025 | 150.84% |
| Jun 30, 2025 | -75.91% |
| Mar 31, 2025 | 122.16% |
| Dec 31, 2024 | -22.74% |
| Sep 30, 2024 | 75.95% |
| Jun 30, 2024 | -63.35% |
| Mar 31, 2024 | 57.46% |
| Dec 31, 2023 | -31.97% |
| Sep 30, 2023 | 98.65% |
| Jun 30, 2023 | -42.26% |
| Mar 31, 2023 | 41.87% |
| Dec 31, 2022 | -24.12% |
| Sep 30, 2022 | 126.93% |
| Jun 30, 2022 | -66.88% |
| Mar 31, 2022 | 41.81% |
| Dec 31, 2021 | -19.00% |
| Sep 30, 2021 | 83.47% |
| Jun 30, 2021 | -69.36% |
| Mar 31, 2021 | -14.53% |